Cemiplimab Improves Health-Related Quality of Life (HRQoL) and Reduces Pain in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Results from a Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial

SKIN The Journal of Cutaneous Medicine(2021)

引用 0|浏览5
暂无评分
关键词
Basal cell carcinoma,Quality of life,Oncology,Phases of clinical research,Medicine,Cutaneous squamous cell carcinoma,Exploratory analysis,Health related quality of life,In patient,Internal medicine,Post hoc
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要